109 related articles for article (PubMed ID: 31053490)
1. A case of neurocognitive deficit strongly related to dasatinib therapy.
Chamoun K; Rabinovich E; Baer L; Fastenau P; Lima M
Hematol Transfus Cell Ther; 2020; 42(1):80-82. PubMed ID: 31053490
[No Abstract] [Full Text] [Related]
2. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
[TBL] [Abstract][Full Text] [Related]
3. [Repeated partially reversible pulmonary arterial hypertension related to dasatinib: a case report and literature review].
Jin J; Xu XM; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):83-7. PubMed ID: 26879609
[TBL] [Abstract][Full Text] [Related]
4. New hope for chronic myelogenous leukemia patients: dasatinib offers better efficacy with shorter treatment.
Naka K; Ichinohe T
Stem Cell Investig; 2016; 3():19. PubMed ID: 27488943
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chronic phase.
Inokuchi K; Kumagai T; Matsuki E; Ohashi K; Shinagawa A; Hatta Y; Takeuchi J; Yoshida C; Wakita H; Kozai Y; Shirasugi Y; Fujisawa S; Iwase O; Yano S; Okamoto S; Oba K; Sakamoto J; Sakamaki H
J Clin Exp Hematop; 2014; 54(3):197-204. PubMed ID: 25501110
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy.
Efficace F; Stagno F; Iurlo A; Breccia M; Cottone F; Bonifacio M; Abruzzese E; Castagnetti F; Caocci G; Crugnola M; Capodanno I; Martino B; Tiribelli M; Patriarca A; Gozzini A; Pregno P; Saussele S; Cascavilla N; Fozza C; Bergamaschi M; Binotto G; Vignetti M; Rosti G
Leukemia; 2020 Feb; 34(2):488-498. PubMed ID: 31477798
[TBL] [Abstract][Full Text] [Related]
8. Predictors of neurocognitive impairment at 2years after a first-episode major depressive disorder.
Gu CZ; He HL; Duan HF; Su ZH; Chen H; Gan JL
Compr Psychiatry; 2016 Jul; 68():24-33. PubMed ID: 27234179
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls.
Zimpfer D; Czerny M; Vogt F; Schuch P; Kramer L; Wolner E; Grimm M
Ann Thorac Surg; 2004 Aug; 78(2):513-8; discussion 518-9. PubMed ID: 15276509
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive subtypes of schizophrenia.
Rangel A; Muñoz C; Ocampo MV; Quintero C; Escobar M; Botero S; Marín C; Jaramillo LE; Sánchez R; Rodríguez-Losada J; Ospina-Duque J; Palacio C; C Arango J; Valencia AV; Aguirre-Acevedo DC; García J
Actas Esp Psiquiatr; 2015; 43(3):80-90. PubMed ID: 25999155
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].
Sato M; Watanabe S; Aoki N; Asakawa K; Moriyama H; Oshima Y; Koya T; Okazuka K; Kikuchi T
Gan To Kagaku Ryoho; 2018 May; 45(5):851-854. PubMed ID: 30026450
[TBL] [Abstract][Full Text] [Related]
12. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
Yang L; Lu N; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].
Makeeva LM; Emelina EI; Gendlin GE; Nikitin IG; Vasyuk YA; Nesvetov VV
Kardiologiia; 2017 Apr; 57(S4):53-60. PubMed ID: 29466183
[TBL] [Abstract][Full Text] [Related]
14. Anti-Neoplastic and Calcium Modulatory Action of Caffeic Acid Phenethyl Ester and Dasatinib in C6 Glial Cells: A Therapeutic Perspective.
Balkhi HM; Gul T; Haq E
CNS Neurol Disord Drug Targets; 2016; 15(1):54-63. PubMed ID: 26553160
[TBL] [Abstract][Full Text] [Related]
15. Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report.
AlJohani NI; Carette S; Lipton JH
J Med Case Rep; 2015 Sep; 9():214. PubMed ID: 26376827
[TBL] [Abstract][Full Text] [Related]
16. Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan".
Sasaki H; Kimizuka Y; Ogata H; Okada Y; Ota S; Sano T; Watanabe C; Maki Y; Yamamoto T; Tagami Y; Miyata J; Hayashi N; Fujikura Y; Kawana A
Intern Med; 2019 Nov; 58(21):3139-3141. PubMed ID: 31292394
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia.
Nishimoto M; Nakamae H; Matsumoto K; Morita K; Koga Y; Momose D; Hino M
Case Rep Hematol; 2017; 2017():4027908. PubMed ID: 28326207
[TBL] [Abstract][Full Text] [Related]
18. A Suspected Case of an Alveolar Haemorrhage Caused by Dasatinib.
Sakoda Y; Arimori Y; Ueno M; Matsumoto T
Intern Med; 2017; 56(2):203-206. PubMed ID: 28090053
[TBL] [Abstract][Full Text] [Related]
19. A Case of Dasatinib-Induced Hemorrhagic Colitis Diagnosed by the Lymphocyte Transformation Test in a Chronic Myeloid Leukemia Patient.
Ahn H; Kwon JE; Sohn SW; Kwon JH; Kim JS; Yoon SS; Kang HR; Hong KS
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):96-99. PubMed ID: 27408366
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug.
Davalos F; Chaucer B; Zafar W; Salman S; Nfonoyim J
Transl Oncol; 2016 Jun; 9(3):248-50. PubMed ID: 27267844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
